Access the full text.
Sign up today, get DeepDyve free for 14 days.
Loading next page...
/lp/wiley/genome-guardian-p53-and-viral-infections-nEy4wQ4G7C
References (80)
-
Elizabeth Turpin, Kimberly Luke, Jeremy Jones, T. Tumpey, K. Konan, S. Schultz‐Cherry (2005)
Influenza Virus Infection Increases p53 Activity: Role of p53 in Cell Death and Viral ReplicationJournal of Virology, 79
-
Toshiki Mori, Yoshio Anazawa, Megumi Iiizumi, S. Fukuda, Yusuke Nakamura, H. Arakawa (2002)
Identification of the interferon regulatory factor 5 gene (IRF-5) as a direct target for p53Oncogene, 21
-
M. Scheffner, J. Huibregtse, R. Vierstra, P. Howley (1993)
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53Cell, 75
-
D. Lane, L. Crawford (1979)
T antigen is bound to a host protein in SY40-transformed cellsNature, 278
-
J. Huibregtse, M. Scheffner, P. Howley (1991)
A cellular protein mediates association of p53 with the E6 oncoprotein of human papillomavirus types 16 or 18.The EMBO Journal, 10
-
K. Sakaguchi, Shinichi Saito, Y. Higashimoto, Siddhartha Roy, C. Anderson, E. Appella (2000)
Damage-mediated Phosphorylation of Human p53 Threonine 18 through a Cascade Mediated by a Casein 1-like KinaseThe Journal of Biological Chemistry, 275
-
H. Yanai, Huixian Chen, Takayuki Inuzuka, S. Kondo, T. Mak, A. Takaoka, K. Honda, T. Taniguchi (2007)
Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppressionProceedings of the National Academy of Sciences, 104
-
T. Nishimura, M. Kohara, K. Izumi, Y. Kasama, Y. Hirata, Ying Huang, M. Shuda, Chise Mukaidani, T. Takano, Yuko Tokunaga, H. Nuriya, Masaaki Satoh, M. Saito, C. Kai, K. Tsukiyama-Kohara (2009)
Hepatitis C Virus Impairs p53 via Persistent Overexpression of 3β-Hydroxysterol Δ24-Reductase*The Journal of Biological Chemistry, 284
-
S. Takada, N. Kaneniwa, N. Tsuchida, K. Koike (1997)
Cytoplasmic retention of the p53 tumor suppressor gene product is observed in the hepatitis B virus X gene-transfected cellsOncogene, 15
-
L. Didcock, D. Young, S. Goodbourn, R. Randall (1999)
The V Protein of Simian Virus 5 Inhibits Interferon Signalling by Targeting STAT1 for Proteasome-Mediated DegradationJournal of Virology, 73
-
Bret Wing, Robert Johnson, E. Huang (1998)
Identification of Positive and Negative Regulatory Regions Involved in Regulating Expression of the Human Cytomegalovirus UL94 Late Promoter: Role of IE2-86 and Cellular p53 in Mediating Negative Regulatory FunctionJournal of Virology, 72
-
C. Muñoz-Fontela, S. Macip, L. Martínez-Sobrido, Lauren Brown, J. Ashour, A. García-Sastre, Sam Lee, S. Aaronson (2008)
Transcriptional role of p53 in interferon-mediated antiviral immunityThe Journal of Experimental Medicine, 205
-
H. Bluyssen, J. Durbin, D. Levy (1996)
ISGF3γ p48, a specificity switch for interferon activated transcription factorsCytokine & Growth Factor Reviews, 7
-
Characterization of a 54 K dalton -
J. Purvis, Kyle Karhohs, Caroline Mock, Eric Batchelor, A. Loewer, G. Lahav (2012)
p53 Dynamics Control Cell FateScience, 336
-
Huaxin Si, E. Robertson (2006)
Kaposi's Sarcoma-Associated Herpesvirus-Encoded Latency-Associated Nuclear Antigen Induces Chromosomal Instability through Inhibition of p53 FunctionJournal of Virology, 80
-
B. Hummer, Xiaoling Li, B. Hassel, B. Hassel (2001)
Role for p53 in Gene Induction by Double-Stranded RNAJournal of Virology, 75
-
Takeshi Tanaka, Kazuaki Inoue, Y. Hayashi, A. Abe, K. Tsukiyama-Kohara, H. Nuriya, Y. Aoki, R. Kawaguchi, Kiichi Kubota, M. Yoshiba, M. Koike, Satoshi Tanaka, M. Kohara (2004)
Virological significance of low‐level hepatitis B virus infection in patients with hepatitis C virus associated liver diseaseJournal of Medical Virology, 72
-
C. Rivas, S. Aaronson, C. Muñoz-Fontela (2010)
Dual Role of p53 in Innate Antiviral ImmunityViruses, 2
-
Yoshitaka Sato, Noriko Shirata, A. Kudoh, S. Iwahori, Sanae Nakayama, T. Murata, Hiroki Isomura, Y. Nishiyama, T. Tsurumi (2009)
Expression of Epstein-Barr virus BZLF1 immediate-early protein induces p53 degradation independent of MDM2, leading to repression of p53-mediated transcription.Virology, 388 1
-
O. Takeuchi, S. Akira (2009)
Innate immunity to virus infectionImmunological Reviews, 227
-
A. Kudoh, M. Fujita, Lumin Zhang, Noriko Shirata, T. Daikoku, Y. Sugaya, Hiroki Isomura, Y. Nishiyama, T. Tsurumi (2005)
Epstein-Barr Virus Lytic Replication Elicits ATM Checkpoint Signal Transduction While Providing an S-phase-like Cellular Environment*Journal of Biological Chemistry, 280
-
V. Saridakis, Y. Sheng, Feroz Sarkari, M. Holowaty, K. Shire, T. Nguyen, Rong-guang Zhang, J. Liao, Weontae Lee, A. Edwards, C. Arrowsmith, L. Frappier (2005)
Structure of the p53 binding domain of HAUSP/USP7 bound to Epstein-Barr nuclear antigen 1 implications for EBV-mediated immortalization.Molecular cell, 18 1
-
Shih-Shin Chang, You-Chang Lo, Huey‐Huey Chua, Hsin-Yi Chiu, S. Tsai, Jen‐Yang Chen, K. Lo, Ching-Hwa Tsai (2008)
Critical Role of p53 in Histone Deacetylase Inhibitor-Induced Epstein-Barr Virus Zta ExpressionJournal of Virology, 82
-
S. Prost, J. Ford, C. Taylor, Jennifer Doig, D. Harrison (1998)
Hepatitis B x Protein Inhibits p53-dependent DNA Repair in Primary Mouse Hepatocytes*The Journal of Biological Chemistry, 273
-
W. Lilyestrom, M. Klein, Rong-guang Zhang, A. Joachimiak, Xiaojiang Chen (2006)
Crystal structure of SV40 large T-antigen bound to p53: interplay between a viral oncoprotein and a cellular tumor suppressor.Genes & development, 20 17
-
S. Hussain, J. Schwank, F. Staib, Xw Wang, CC Harris (2007)
TP53 mutations and hepatocellular carcinoma: insights into the etiology and pathogenesis of liver cancerOncogene, 26
-
M. Uittenbogaard, H. Giebler, D. Reisman, J. Nyborg (1995)
Transcriptional Repression of p53 by Human T-cell Leukemia Virus Type I Tax Protein (*)The Journal of Biological Chemistry, 270
-
S. Baker, E. Fearon, J. Nigro, S. Hamilton, A. Preisinger, J. Jessup, P. Vantuinen, D. Ledbetter, D. Barker, Y. Nakamura, Raymond White, B. Vogelstein (1989)
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas.Science, 244 4901
-
Yoshitaka Sato, T. Kamura, Noriko Shirata, T. Murata, A. Kudoh, S. Iwahori, Sanae Nakayama, Hiroki Isomura, Y. Nishiyama, T. Tsurumi (2009)
Degradation of Phosphorylated p53 by Viral Protein-ECS E3 Ligase ComplexPLoS Pathogens, 5
-
Nishimura Nishimura, Kohara Kohara, Izumi Izumi (2009)
Hepatitis C virus impairs p53 via persistent overexpression of 3beta‐hydroxysterol Delta24‐reductaseJournal of Biological Chemistry, 284
-
O. Terrier, L. Josset, J. Textoris, V. Marcel, G. Cartet, O. Ferraris, C. N'guyen, B. Lina, Jean-Jacques Diaz, J. Bourdon, M. Rosa-Calatrava (2011)
Cellular transcriptional profiling in human lung epithelial cells infected by different subtypes of influenza A viruses reveals an overall down-regulation of the host p53 pathwayVirology Journal, 8
-
J. Bourdon, V. Laurenzi, G. Melino, D. Lane (2003)
p53: 25 years of research and more questions to answerCell Death and Differentiation, 10
-
M. Oren (2003)
Decision making by p53: life, death and cancerCell Death and Differentiation, 10
-
Chaowei Wu, Irene Miloslavskaya, S. Demontis, R. Maestro, K. Galaktionov (2004)
Regulation of cellular response to oncogenic and oxidative stress by Seladin-1Nature, 432
-
E. Querido, P. Blanchette, Qin Yan, T. Kamura, M. Morrison, D. Boivin, W. Kaelin, R. Conaway, J. Conaway, P. Branton (2001)
Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullin-containing complex.Genes & development, 15 23
-
M. Taura, Ayaka Eguma, M. Suico, T. Shuto, Tomoaki Koga, Kensei Komatsu, Takefumi Komune, Takashi Sato, H. Saya, Jian-Dong Li, H. Kai (2008)
p53 Regulates Toll-Like Receptor 3 Expression and Function in Human Epithelial Cell LinesMolecular and Cellular Biology, 28
-
B. Sawaya, K. Khalili, W. Mercer, L. Denisova, S. Amini (1998)
Cooperative Actions of HIV-1 Vpr and p53 Modulate Viral Gene Transcription*The Journal of Biological Chemistry, 273
-
A. Takaoka, S. Hayakawa, H. Yanai, D. Stoiber, Hideo Negishi, H. Kikuchi, S. Sasaki, K. Imai, T. Shibue, K. Honda, T. Taniguchi (2003)
Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.Nature, 424 6948
-
R. Reid, P. Lindholm, A. Mireskandari, J. Dittmer, J. Brady (1993)
Stabilization of wild-type p53 in human T-lymphocytes transformed by HTLV-I.Oncogene, 8 11
-
(1990)
Proceedings of the National Academy of Sciences of the United States of America. Annual subject and author indexes.Proceedings of the National Academy of Sciences of the United States of America, 87 Suppl
-
A. Petitjean, E. Mathé, S. Kato, C. Ishioka, S. Tavtigian, P. Hainaut, M. Olivier (2007)
Impact of mutant p53 functional properties on TP53 mutation patterns and tumor phenotype: lessons from recent developments in the IARC TP53 databaseHuman Mutation, 28
-
D. Linzer, A. Levine (1979)
Characterization of a 54K Dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cellsCell, 17
-
P. Farazi, R. DePinho (2006)
Hepatocellular carcinoma pathogenesis: from genes to environmentNature Reviews Cancer, 6
-
Yoshitaka Sato, Noriko Shirata, T. Murata, Sho Nakasu, A. Kudoh, S. Iwahori, Sanae Nakayama, S. Chiba, Hiroki Isomura, T. Kanda, T. Tsurumi (2010)
Transient increases in p53-responsible gene expression at early stages of Epstein-Barr virus productive replicationCell Cycle, 9
-
Chikako Nakai-Murakami, M. Shimura, M. Kinomoto, Y. Takizawa, K. Tokunaga, T. Taguchi, Shigeki Hoshino, K. Miyagawa, T. Sata, H. Kurumizaka, A. Yuo, Y. Ishizaka (2007)
HIV-1 Vpr induces ATM-dependent cellular signal with enhanced homologous recombinationOncogene, 26
-
J. Friborg, W. Kong, M. Hottiger, G. Nabel (1999)
p53 inhibition by the LANA protein of KSHV protects against cell deathNature, 402
-
E. Pauls, J. Senserrich, B. Clotet, J. Esté (2006)
Inhibition of HIV‐1 replication by RNA interference of p53 expressionJournal of Leukocyte Biology, 80
-
Sakaguchi Sakaguchi, Saito Saito, Higashimoto Higashimoto, Roy Roy, Anderson Anderson, Appella Appella (2000)
Damage‐mediated phosphorylation of human p53 threonine 18 through a cascade mediated by a case in 1‐like kinase. Effect on Mdm2 bindingJournal of Biological Chemistry, 275
-
R. Daniel, G. Kao, K. Taganov, J. Greger, O. Favorova, G. Merkel, T. Yen, R. Katz, A. Skalka (2003)
Evidence that the retroviral DNA integration process triggers an ATR-dependent DNA damage responseProceedings of the National Academy of Sciences of the United States of America, 100
-
K. Vousden, Xin Lu (2002)
Live or let die: the cell's response to p53Nature Reviews Cancer, 2
-
C. Sherr (2004)
Principles of Tumor SuppressionCell, 116
-
D. McGivern, S. Lemon (2009)
Tumor suppressors, chromosomal instability, and hepatitis C virus-associated liver cancer.Annual review of pathology, 4
-
Jennifer Kwak, P. Ongusaha, T. Ouchi, Sam Lee (2003)
IFI16 as a Negative Regulator in the Regulation of p53 and p21Waf1*Journal of Biological Chemistry, 278
-
Claudio Santos, F. Vega, S. Blanco, R. Barcia, P. Lazo (2004)
The vaccinia virus B1R kinase induces p53 downregulation by an Mdm2-dependent mechanism.Virology, 328 2
-
B. Hale, R. Randall, J. Ortín, D. Jackson (2008)
The multifunctional NS1 protein of influenza A viruses.The Journal of general virology, 89 Pt 10
-
R. Brosh, V. Rotter (2009)
When mutants gain new powers: news from the mutant p53 fieldNature Reviews Cancer, 9
-
K. Rosenke, Melanie Samuel, Eric McDowell, Melissa Toerne, E. Fortunato (2006)
An intact sequence-specific DNA-binding domain is required for human cytomegalovirus-mediated sequestration of p53 and may promote in vivo binding to the viral genome during infection.Virology, 348 1
-
B. Vogelstein, D. Lane, A. Levine (2000)
Surfing the p53 networkNature, 408
-
C. Muñoz-Fontela, Michael Pazos, Igotz Delgado, W. Murk, Sathish Mungamuri, Sam Lee, A. García-Sastre, T. Moran, S. Aaronson (2011)
p53 Serves as a Host Antiviral Factor That Enhances Innate and Adaptive Immune Responses to Influenza A VirusThe Journal of Immunology, 187
-
K. Hacke, Bladimiro Rincón-Orozco, Gilles Buchwalter, S. Siehler, B. Wasylyk, L. Wiesmüller, F. Rösl (2010)
Regulation of MCP-1 chemokine transcription by p53Molecular Cancer, 9
-
Xiaodu Wang, Yang Shen, Yafeng Qiu, Zixue Shi, Donghua Shao, Pei-Wei Chen, G. Tong, Zhiyong Ma (2010)
The non-structural (NS1) protein of influenza A virus associates with p53 and inhibits p53-mediated transcriptional activity and apoptosis.Biochemical and biophysical research communications, 395 1
-
Yanping Zhang, Yue Xiong (2001)
Control of p53 ubiquitination and nuclear export by MDM2 and ARF.Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research, 12 4
-
L. Duan, I. Ozaki, J. Oakes, J. Taylor, K. Khalili, R. Pomerantz (1994)
The tumor suppressor protein p53 strongly alters human immunodeficiency virus type 1 replicationJournal of Virology, 68
-
Taisuke Izumi, Katsuhiro Io, M. Matsui, Kotaro Shirakawa, Masanobu Shinohara, Y. Nagai, M. Kawahara, Masayuki Kobayashi, H. Kondoh, N. Misawa, Y. Koyanagi, T. Uchiyama, A. Takaori-Kondo (2010)
HIV-1 viral infectivity factor interacts with TP53 to induce G2 cell cycle arrest and positively regulate viral replicationProceedings of the National Academy of Sciences, 107
-
A. Wali, D. Strayer (1999)
Infection with vaccinia virus alters regulation of cell cycle progression.DNA and cell biology, 18 11
-
A. Braithwaite, C. Prives (2006)
p53: more research and more questionsCell Death and Differentiation, 13
-
A. Bluyssen, J. Durbin, D. Levy (1996)
ISGF3 gamma p48, a specificity switch for interferon activated transcription factors.Cytokine & growth factor reviews, 7 1
-
N. Casavant, M. Luo, M. Luo, K. Rosenke, T. Winegardner, A. Zurawska, E. Fortunato (2006)
Potential Role for p53 in the Permissive Life Cycle of Human CytomegalovirusJournal of Virology, 80
-
Xiao-Peng Zhang, Feng Liu, Wei Wang (2011)
Two-phase dynamics of p53 in the DNA damage responseProceedings of the National Academy of Sciences, 108
-
N. Dharel, N. Kato, R. Muroyama, Hiroyoshi Taniguchi, M. Otsuka, Yue Wang, A. Jazag, R. Shao, Jin-Hai Chang, Mark Adler, T. Kawabe, M. Omata (2007)
Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virusHepatology, 47
-
A. Tanaka, C. Takahashi, S. Yamaoka, T. Nosaka, M. Maki, Masakazu Hatanaka (1990)
Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro.Proceedings of the National Academy of Sciences of the United States of America, 87
-
Yan Shen, Eileen White (2001)
p53-dependent apoptosis pathways.Advances in cancer research, 82
-
C. Pise-Masison, K. Choi, M. Radonovich, J. Dittmer, Seong-Jin Kim, J. Brady (1998)
Inhibition of p53 Transactivation Function by the Human T-Cell Lymphotropic Virus Type 1 Tax ProteinJournal of Virology, 72
-
A. Greenway, D. McPhee, Kelly Allen, R. Johnstone, G. Holloway, J. Mills, A. Azad, S. Sankovich, P. Lambert (2002)
Human Immunodeficiency Virus Type 1 Nef Binds to Tumor Suppressor p53 and Protects Cells against p53-Mediated ApoptosisJournal of Virology, 76
-
Toru Ouchi, Sam Lee, Mutsuko Ouchi, Stuart Aaronson, Curt Horvath (2000)
Collaboration of signal transducer and activator of transcription 1 (STAT1) and BRCA1 in differential regulation of IFN-gamma target genes.Proceedings of the National Academy of Sciences of the United States of America, 97 10
-
R. Lowy (2003)
INFLUENZA VIRUS INDUCTION OF APOPTOSIS BY INTRINSIC AND EXTRINSIC MECHANISMSInternational Reviews of Immunology, 22
-
M. Scheffner, B. Werness, J. Huibregtse, A. Levine, P. Howley (1990)
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53Cell, 63
-
Qiliang Cai, J. Knight, S. Verma, P. Zald, E. Robertson (2006)
EC5S Ubiquitin Complex Is Recruited by KSHV Latent Antigen LANA for Degradation of the VHL and p53 Tumor SuppressorsPLoS Pathogens, 2
-
J. Parisien, J. Lau, Jason Rodriguez, C. Ulane, C. Horvath (2002)
Selective STAT Protein Degradation Induced by Paramyxoviruses Requires both STAT1 and STAT2 but Is Independent of Alpha/Beta Interferon Signal TransductionJournal of Virology, 76
- Publisher
- Wiley
- Copyright
- Copyright © 2013 John Wiley & Sons, Ltd.
- ISSN
- 1052-9276
- eISSN
- 1099-1654
- DOI
- 10.1002/rmv.1738
- pmid
- 23255396
- Publisher site
- See Article on Publisher Site
Abstract
SUMMARY Because virus infections elicit various cellular responses that inhibit viral replication and growth, viruses must intervene to attenuate antiviral measures in order to thrive. The genome guardian p53 plays a central part not only in DNA damage responses, inducing cell cycle arrest or apoptosis, but also in the innate host immune control of viral infections by orchestrating diverse signaling pathways originating from many different cellular receptors and sensors. Many viruses have acquired sophisticated mechanisms to regulate p53 functions by deploying subversive proteins and modulating its post‐transcriptional status. In this review, we overview the mechanisms by which DNA and RNA viruses manage p53 signaling in favor of their continued survival. Copyright © 2012 John Wiley & Sons, Ltd.
Journal
Reviews in Medical Virology – Wiley
Published: Jul 1, 2013